Global Airsickness Treatment Market

Airsickness Treatment Comprehensive Study by Application (Adults, Children), Type (Anticholinergic, Antihistamines, Other), Treatment (Medication, Non-Medication, Others), Route of Administration (Oral, Transdermal, Parenteral, Other), Distribution Channel (Retail Pharmacies, Online Pharmacies, Others) Players and Region - Global Market Outlook to 2026

Airsickness Treatment Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Airsickness Treatment Market Scope
Airsickness is a specific kind of sickness that is induced by travel and is considered a normal response in healthy people. Airsickness happens when the central nervous system receives conflicting messages from the body (including the inner ear, eyes and muscles) affecting balance and equilibrium. Whereas commercial airline passengers may merely feel poorly, the impact of airsickness on military aircrew may result in a decrement in performance and adversely have an effect on the mission. The inner ear is especially important in the maintenance of balance and equilibrium because it contains sensors for both angular (rotational) and linear motion. Airsickness is typically a mix of spatial disorientation, nausea and vomiting. Common symptoms of air sickness include: Nausea, vomiting, vertigo, loss of appetite, cold sweating, skin pallor, difficulty concentrating, confusion, drowsiness, headache, and increased fatigue. Severe airsickness may cause a person to become fully incapacitated.

The Airsickness Treatment market study is segmented, by Application (Adults and Children) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, and new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Airsickness Treatment market throughout the predicted period.

GlaxoSmithKline plc (United Kingdom), Perrigo Company plc (Ireland), Prestige Brands (United States), WellSpring Pharmaceutical Corporation (United States), Caleb Pharmaceuticals (Taiwan), Myungmoon Pharm Co. (South Korea), Baxter International (United States), Reliefband Technologies LLC. (United States) and CVS Health (United States) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AMA Research has segmented the market of Global Airsickness Treatment market by Type, Application and Region.

On the basis of geography, the market of Airsickness Treatment has been segmented into South America (Brazil, Argentina, Chile, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Singapore, Indonesia, Thailand, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Spain, Sweden, Belgium, Finland, Denmark, Russia, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • Advent of Nauseogenic Information Technology

Market Drivers
  • Increasing number of Air Passenger
  • Changing Lifestyle and Increasing Disposable Income
  • Rising Adoption of Prescription Seasickness Medicine

Opportunities
  • Increase in Awareness of the Disease
  • Rising in the Number of Domestic and International Travelers

Restraints
  • Reluctance in Emerging Countries due to Higher Cost of Prescription Drugs
  • Excessive Reliance on the OTC and Traditional Medicines

Challenges
  • Stringent Government Rules and Regulations


Key Target Audience
Raw Material Supplier, Airsickness Treatment Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

Report Objectives / Segmentation Covered

By Application
  • Adults
  • Children
By Type
  • Anticholinergic
  • Antihistamines
  • Other

By Treatment
  • Medication
  • Non-Medication
  • Others

By Route of Administration
  • Oral
  • Transdermal
  • Parenteral
  • Other

By Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Chile
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Indonesia
    • Thailand
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Spain
    • Sweden
    • Belgium
    • Finland
    • Denmark
    • Russia
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing number of Air Passenger
      • 3.2.2. Changing Lifestyle and Increasing Disposable Income
      • 3.2.3. Rising Adoption of Prescription Seasickness Medicine
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Rules and Regulations
    • 3.4. Market Trends
      • 3.4.1. Advent of Nauseogenic Information Technology
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Airsickness Treatment, by Application, Type, Treatment, Route of Administration, Distribution Channel and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Airsickness Treatment (Value)
      • 5.2.1. Global Airsickness Treatment by: Type (Value)
        • 5.2.1.1. Anticholinergic
        • 5.2.1.2. Antihistamines
        • 5.2.1.3. Other
      • 5.2.2. Global Airsickness Treatment by: Application (Value)
        • 5.2.2.1. Adults
        • 5.2.2.2. Children
      • 5.2.3. Global Airsickness Treatment by: Type (Value)
        • 5.2.3.1. Anticholinergic
        • 5.2.3.2. Antihistamines
        • 5.2.3.3. Other
      • 5.2.4. Global Airsickness Treatment by: Treatment (Value)
        • 5.2.4.1. Medication
        • 5.2.4.2. Non-Medication
        • 5.2.4.3. Others
      • 5.2.5. Global Airsickness Treatment by: Route of Administration (Value)
        • 5.2.5.1. Oral
        • 5.2.5.2. Transdermal
        • 5.2.5.3. Parenteral
        • 5.2.5.4. Other
      • 5.2.6. Global Airsickness Treatment by: Distribution Channel (Value)
        • 5.2.6.1. Retail Pharmacies
        • 5.2.6.2. Online Pharmacies
        • 5.2.6.3. Others
      • 5.2.7. Global Airsickness Treatment Region
        • 5.2.7.1. South America
          • 5.2.7.1.1. Brazil
          • 5.2.7.1.2. Argentina
          • 5.2.7.1.3. Chile
          • 5.2.7.1.4. Rest of South America
        • 5.2.7.2. Asia Pacific
          • 5.2.7.2.1. China
          • 5.2.7.2.2. Japan
          • 5.2.7.2.3. India
          • 5.2.7.2.4. South Korea
          • 5.2.7.2.5. Singapore
          • 5.2.7.2.6. Indonesia
          • 5.2.7.2.7. Thailand
          • 5.2.7.2.8. Australia
          • 5.2.7.2.9. Rest of Asia-Pacific
        • 5.2.7.3. Europe
          • 5.2.7.3.1. Germany
          • 5.2.7.3.2. France
          • 5.2.7.3.3. Italy
          • 5.2.7.3.4. United Kingdom
          • 5.2.7.3.5. Netherlands
          • 5.2.7.3.6. Spain
          • 5.2.7.3.7. Sweden
          • 5.2.7.3.8. Belgium
          • 5.2.7.3.9. Finland
          • 5.2.7.3.10. Denmark
          • 5.2.7.3.11. Russia
          • 5.2.7.3.12. Rest of Europe
        • 5.2.7.4. MEA
          • 5.2.7.4.1. Middle East
          • 5.2.7.4.2. Africa
        • 5.2.7.5. North America
          • 5.2.7.5.1. United States
          • 5.2.7.5.2. Canada
          • 5.2.7.5.3. Mexico
  • 6. Airsickness Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Perrigo Company plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Prestige Brands (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. WellSpring Pharmaceutical Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Caleb Pharmaceuticals (Taiwan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Myungmoon Pharm Co. (South Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Baxter International (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Reliefband Technologies LLC. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CVS Health (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Airsickness Treatment Sale, by Application, Type, Treatment, Route of Administration, Distribution Channel and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Airsickness Treatment (Value)
      • 7.2.1. Global Airsickness Treatment by: Type (Value)
        • 7.2.1.1. Anticholinergic
        • 7.2.1.2. Antihistamines
        • 7.2.1.3. Other
      • 7.2.2. Global Airsickness Treatment by: Application (Value)
        • 7.2.2.1. Adults
        • 7.2.2.2. Children
      • 7.2.3. Global Airsickness Treatment by: Type (Value)
        • 7.2.3.1. Anticholinergic
        • 7.2.3.2. Antihistamines
        • 7.2.3.3. Other
      • 7.2.4. Global Airsickness Treatment by: Treatment (Value)
        • 7.2.4.1. Medication
        • 7.2.4.2. Non-Medication
        • 7.2.4.3. Others
      • 7.2.5. Global Airsickness Treatment by: Route of Administration (Value)
        • 7.2.5.1. Oral
        • 7.2.5.2. Transdermal
        • 7.2.5.3. Parenteral
        • 7.2.5.4. Other
      • 7.2.6. Global Airsickness Treatment by: Distribution Channel (Value)
        • 7.2.6.1. Retail Pharmacies
        • 7.2.6.2. Online Pharmacies
        • 7.2.6.3. Others
      • 7.2.7. Global Airsickness Treatment Region
        • 7.2.7.1. South America
          • 7.2.7.1.1. Brazil
          • 7.2.7.1.2. Argentina
          • 7.2.7.1.3. Chile
          • 7.2.7.1.4. Rest of South America
        • 7.2.7.2. Asia Pacific
          • 7.2.7.2.1. China
          • 7.2.7.2.2. Japan
          • 7.2.7.2.3. India
          • 7.2.7.2.4. South Korea
          • 7.2.7.2.5. Singapore
          • 7.2.7.2.6. Indonesia
          • 7.2.7.2.7. Thailand
          • 7.2.7.2.8. Australia
          • 7.2.7.2.9. Rest of Asia-Pacific
        • 7.2.7.3. Europe
          • 7.2.7.3.1. Germany
          • 7.2.7.3.2. France
          • 7.2.7.3.3. Italy
          • 7.2.7.3.4. United Kingdom
          • 7.2.7.3.5. Netherlands
          • 7.2.7.3.6. Spain
          • 7.2.7.3.7. Sweden
          • 7.2.7.3.8. Belgium
          • 7.2.7.3.9. Finland
          • 7.2.7.3.10. Denmark
          • 7.2.7.3.11. Russia
          • 7.2.7.3.12. Rest of Europe
        • 7.2.7.4. MEA
          • 7.2.7.4.1. Middle East
          • 7.2.7.4.2. Africa
        • 7.2.7.5. North America
          • 7.2.7.5.1. United States
          • 7.2.7.5.2. Canada
          • 7.2.7.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Airsickness Treatment: by Type(USD Million)
  • Table 2. Airsickness Treatment Anticholinergic , by Region USD Million (2015-2020)
  • Table 3. Airsickness Treatment Antihistamines , by Region USD Million (2015-2020)
  • Table 4. Airsickness Treatment Other , by Region USD Million (2015-2020)
  • Table 5. Airsickness Treatment: by Application(USD Million)
  • Table 6. Airsickness Treatment Adults , by Region USD Million (2015-2020)
  • Table 7. Airsickness Treatment Children , by Region USD Million (2015-2020)
  • Table 8. Airsickness Treatment: by Type(USD Million)
  • Table 9. Airsickness Treatment Anticholinergic , by Region USD Million (2015-2020)
  • Table 10. Airsickness Treatment Antihistamines , by Region USD Million (2015-2020)
  • Table 11. Airsickness Treatment Other , by Region USD Million (2015-2020)
  • Table 12. Airsickness Treatment: by Treatment(USD Million)
  • Table 13. Airsickness Treatment Medication , by Region USD Million (2015-2020)
  • Table 14. Airsickness Treatment Non-Medication , by Region USD Million (2015-2020)
  • Table 15. Airsickness Treatment Others , by Region USD Million (2015-2020)
  • Table 16. Airsickness Treatment: by Route of Administration(USD Million)
  • Table 17. Airsickness Treatment Oral , by Region USD Million (2015-2020)
  • Table 18. Airsickness Treatment Transdermal , by Region USD Million (2015-2020)
  • Table 19. Airsickness Treatment Parenteral , by Region USD Million (2015-2020)
  • Table 20. Airsickness Treatment Other , by Region USD Million (2015-2020)
  • Table 21. Airsickness Treatment: by Distribution Channel(USD Million)
  • Table 22. Airsickness Treatment Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 23. Airsickness Treatment Online Pharmacies , by Region USD Million (2015-2020)
  • Table 24. Airsickness Treatment Others , by Region USD Million (2015-2020)
  • Table 25. South America Airsickness Treatment, by Country USD Million (2015-2020)
  • Table 26. South America Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 27. South America Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 28. South America Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 29. South America Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 30. South America Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 31. Brazil Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 32. Brazil Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 33. Brazil Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 34. Brazil Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 35. Brazil Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 36. Argentina Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 37. Argentina Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 38. Argentina Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 39. Argentina Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 40. Argentina Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 41. Chile Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 42. Chile Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 43. Chile Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 44. Chile Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 45. Chile Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 46. Rest of South America Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 47. Rest of South America Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 48. Rest of South America Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 49. Rest of South America Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 50. Rest of South America Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 51. Asia Pacific Airsickness Treatment, by Country USD Million (2015-2020)
  • Table 52. Asia Pacific Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 53. Asia Pacific Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 54. Asia Pacific Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 55. Asia Pacific Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 56. Asia Pacific Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 57. China Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 58. China Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 59. China Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 60. China Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 61. China Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 62. Japan Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 63. Japan Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 64. Japan Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 65. Japan Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 66. Japan Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 67. India Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 68. India Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 69. India Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 70. India Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 71. India Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 72. South Korea Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 73. South Korea Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 74. South Korea Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 75. South Korea Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 76. South Korea Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 77. Singapore Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 78. Singapore Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 79. Singapore Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 80. Singapore Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 81. Singapore Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 82. Indonesia Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 83. Indonesia Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 84. Indonesia Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 85. Indonesia Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 86. Indonesia Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 87. Thailand Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 88. Thailand Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 89. Thailand Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 90. Thailand Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 91. Thailand Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 92. Australia Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 93. Australia Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 94. Australia Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 95. Australia Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 96. Australia Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 97. Rest of Asia-Pacific Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 98. Rest of Asia-Pacific Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 99. Rest of Asia-Pacific Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 100. Rest of Asia-Pacific Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 101. Rest of Asia-Pacific Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 102. Europe Airsickness Treatment, by Country USD Million (2015-2020)
  • Table 103. Europe Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 104. Europe Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 105. Europe Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 106. Europe Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 107. Europe Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 108. Germany Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 109. Germany Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 110. Germany Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 111. Germany Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 112. Germany Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 113. France Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 114. France Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 115. France Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 116. France Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 117. France Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 118. Italy Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 119. Italy Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 120. Italy Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 121. Italy Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 122. Italy Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 123. United Kingdom Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 124. United Kingdom Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 125. United Kingdom Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 126. United Kingdom Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 127. United Kingdom Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 128. Netherlands Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 129. Netherlands Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 130. Netherlands Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 131. Netherlands Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 132. Netherlands Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 133. Spain Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 134. Spain Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 135. Spain Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 136. Spain Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 137. Spain Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 138. Sweden Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 139. Sweden Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 140. Sweden Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 141. Sweden Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 142. Sweden Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 143. Belgium Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 144. Belgium Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 145. Belgium Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 146. Belgium Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 147. Belgium Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 148. Finland Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 149. Finland Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 150. Finland Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 151. Finland Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 152. Finland Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 153. Denmark Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 154. Denmark Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 155. Denmark Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 156. Denmark Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 157. Denmark Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 158. Russia Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 159. Russia Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 160. Russia Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 161. Russia Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 162. Russia Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 163. Rest of Europe Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 164. Rest of Europe Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 165. Rest of Europe Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 166. Rest of Europe Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 167. Rest of Europe Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 168. MEA Airsickness Treatment, by Country USD Million (2015-2020)
  • Table 169. MEA Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 170. MEA Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 171. MEA Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 172. MEA Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 173. MEA Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 174. Middle East Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 175. Middle East Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 176. Middle East Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 177. Middle East Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 178. Middle East Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 179. Africa Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 180. Africa Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 181. Africa Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 182. Africa Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 183. Africa Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 184. North America Airsickness Treatment, by Country USD Million (2015-2020)
  • Table 185. North America Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 186. North America Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 187. North America Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 188. North America Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 189. North America Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 190. United States Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 191. United States Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 192. United States Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 193. United States Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 194. United States Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 195. Canada Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 196. Canada Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 197. Canada Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 198. Canada Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 199. Canada Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 200. Mexico Airsickness Treatment, by Application USD Million (2015-2020)
  • Table 201. Mexico Airsickness Treatment, by Type USD Million (2015-2020)
  • Table 202. Mexico Airsickness Treatment, by Treatment USD Million (2015-2020)
  • Table 203. Mexico Airsickness Treatment, by Route of Administration USD Million (2015-2020)
  • Table 204. Mexico Airsickness Treatment, by Distribution Channel USD Million (2015-2020)
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Airsickness Treatment: by Type(USD Million)
  • Table 215. Airsickness Treatment Anticholinergic , by Region USD Million (2021-2026)
  • Table 216. Airsickness Treatment Antihistamines , by Region USD Million (2021-2026)
  • Table 217. Airsickness Treatment Other , by Region USD Million (2021-2026)
  • Table 218. Airsickness Treatment: by Application(USD Million)
  • Table 219. Airsickness Treatment Adults , by Region USD Million (2021-2026)
  • Table 220. Airsickness Treatment Children , by Region USD Million (2021-2026)
  • Table 221. Airsickness Treatment: by Type(USD Million)
  • Table 222. Airsickness Treatment Anticholinergic , by Region USD Million (2021-2026)
  • Table 223. Airsickness Treatment Antihistamines , by Region USD Million (2021-2026)
  • Table 224. Airsickness Treatment Other , by Region USD Million (2021-2026)
  • Table 225. Airsickness Treatment: by Treatment(USD Million)
  • Table 226. Airsickness Treatment Medication , by Region USD Million (2021-2026)
  • Table 227. Airsickness Treatment Non-Medication , by Region USD Million (2021-2026)
  • Table 228. Airsickness Treatment Others , by Region USD Million (2021-2026)
  • Table 229. Airsickness Treatment: by Route of Administration(USD Million)
  • Table 230. Airsickness Treatment Oral , by Region USD Million (2021-2026)
  • Table 231. Airsickness Treatment Transdermal , by Region USD Million (2021-2026)
  • Table 232. Airsickness Treatment Parenteral , by Region USD Million (2021-2026)
  • Table 233. Airsickness Treatment Other , by Region USD Million (2021-2026)
  • Table 234. Airsickness Treatment: by Distribution Channel(USD Million)
  • Table 235. Airsickness Treatment Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 236. Airsickness Treatment Online Pharmacies , by Region USD Million (2021-2026)
  • Table 237. Airsickness Treatment Others , by Region USD Million (2021-2026)
  • Table 238. South America Airsickness Treatment, by Country USD Million (2021-2026)
  • Table 239. South America Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 240. South America Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 241. South America Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 242. South America Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 243. South America Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 244. Brazil Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 245. Brazil Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 246. Brazil Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 247. Brazil Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 248. Brazil Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 249. Argentina Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 250. Argentina Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 251. Argentina Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 252. Argentina Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 253. Argentina Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 254. Chile Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 255. Chile Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 256. Chile Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 257. Chile Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 258. Chile Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 259. Rest of South America Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 260. Rest of South America Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 261. Rest of South America Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 262. Rest of South America Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 263. Rest of South America Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 264. Asia Pacific Airsickness Treatment, by Country USD Million (2021-2026)
  • Table 265. Asia Pacific Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 266. Asia Pacific Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 267. Asia Pacific Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 268. Asia Pacific Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 269. Asia Pacific Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 270. China Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 271. China Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 272. China Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 273. China Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 274. China Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 275. Japan Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 276. Japan Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 277. Japan Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 278. Japan Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 279. Japan Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 280. India Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 281. India Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 282. India Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 283. India Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 284. India Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 285. South Korea Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 286. South Korea Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 287. South Korea Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 288. South Korea Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 289. South Korea Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 290. Singapore Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 291. Singapore Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 292. Singapore Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 293. Singapore Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 294. Singapore Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 295. Indonesia Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 296. Indonesia Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 297. Indonesia Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 298. Indonesia Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 299. Indonesia Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 300. Thailand Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 301. Thailand Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 302. Thailand Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 303. Thailand Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 304. Thailand Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 305. Australia Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 306. Australia Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 307. Australia Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 308. Australia Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 309. Australia Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 310. Rest of Asia-Pacific Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 311. Rest of Asia-Pacific Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 312. Rest of Asia-Pacific Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 313. Rest of Asia-Pacific Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 314. Rest of Asia-Pacific Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 315. Europe Airsickness Treatment, by Country USD Million (2021-2026)
  • Table 316. Europe Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 317. Europe Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 318. Europe Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 319. Europe Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 320. Europe Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 321. Germany Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 322. Germany Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 323. Germany Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 324. Germany Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 325. Germany Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 326. France Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 327. France Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 328. France Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 329. France Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 330. France Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 331. Italy Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 332. Italy Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 333. Italy Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 334. Italy Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 335. Italy Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 336. United Kingdom Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 337. United Kingdom Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 338. United Kingdom Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 339. United Kingdom Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 340. United Kingdom Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 341. Netherlands Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 342. Netherlands Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 343. Netherlands Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 344. Netherlands Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 345. Netherlands Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 346. Spain Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 347. Spain Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 348. Spain Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 349. Spain Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 350. Spain Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 351. Sweden Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 352. Sweden Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 353. Sweden Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 354. Sweden Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 355. Sweden Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 356. Belgium Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 357. Belgium Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 358. Belgium Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 359. Belgium Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 360. Belgium Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 361. Finland Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 362. Finland Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 363. Finland Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 364. Finland Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 365. Finland Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 366. Denmark Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 367. Denmark Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 368. Denmark Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 369. Denmark Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 370. Denmark Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 371. Russia Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 372. Russia Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 373. Russia Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 374. Russia Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 375. Russia Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 376. Rest of Europe Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 377. Rest of Europe Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 378. Rest of Europe Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 379. Rest of Europe Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 380. Rest of Europe Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 381. MEA Airsickness Treatment, by Country USD Million (2021-2026)
  • Table 382. MEA Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 383. MEA Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 384. MEA Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 385. MEA Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 386. MEA Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 387. Middle East Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 388. Middle East Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 389. Middle East Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 390. Middle East Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 391. Middle East Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 392. Africa Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 393. Africa Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 394. Africa Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 395. Africa Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 396. Africa Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 397. North America Airsickness Treatment, by Country USD Million (2021-2026)
  • Table 398. North America Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 399. North America Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 400. North America Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 401. North America Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 402. North America Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 403. United States Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 404. United States Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 405. United States Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 406. United States Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 407. United States Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 408. Canada Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 409. Canada Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 410. Canada Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 411. Canada Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 412. Canada Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 413. Mexico Airsickness Treatment, by Application USD Million (2021-2026)
  • Table 414. Mexico Airsickness Treatment, by Type USD Million (2021-2026)
  • Table 415. Mexico Airsickness Treatment, by Treatment USD Million (2021-2026)
  • Table 416. Mexico Airsickness Treatment, by Route of Administration USD Million (2021-2026)
  • Table 417. Mexico Airsickness Treatment, by Distribution Channel USD Million (2021-2026)
  • Table 418. Research Programs/Design for This Report
  • Table 419. Key Data Information from Secondary Sources
  • Table 420. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Airsickness Treatment: by Type USD Million (2015-2020)
  • Figure 5. Global Airsickness Treatment: by Application USD Million (2015-2020)
  • Figure 6. Global Airsickness Treatment: by Type USD Million (2015-2020)
  • Figure 7. Global Airsickness Treatment: by Treatment USD Million (2015-2020)
  • Figure 8. Global Airsickness Treatment: by Route of Administration USD Million (2015-2020)
  • Figure 9. Global Airsickness Treatment: by Distribution Channel USD Million (2015-2020)
  • Figure 10. South America Airsickness Treatment Share (%), by Country
  • Figure 11. Asia Pacific Airsickness Treatment Share (%), by Country
  • Figure 12. Europe Airsickness Treatment Share (%), by Country
  • Figure 13. MEA Airsickness Treatment Share (%), by Country
  • Figure 14. North America Airsickness Treatment Share (%), by Country
  • Figure 15. Global Airsickness Treatment share by Players 2020 (%)
  • Figure 16. Global Airsickness Treatment share by Players (Top 3) 2020(%)
  • Figure 17. Global Airsickness Treatment share by Players (Top 5) 2020(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 21. Perrigo Company plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Perrigo Company plc (Ireland) Revenue: by Geography 2020
  • Figure 23. Prestige Brands (United States) Revenue, Net Income and Gross profit
  • Figure 24. Prestige Brands (United States) Revenue: by Geography 2020
  • Figure 25. WellSpring Pharmaceutical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. WellSpring Pharmaceutical Corporation (United States) Revenue: by Geography 2020
  • Figure 27. Caleb Pharmaceuticals (Taiwan) Revenue, Net Income and Gross profit
  • Figure 28. Caleb Pharmaceuticals (Taiwan) Revenue: by Geography 2020
  • Figure 29. Myungmoon Pharm Co. (South Korea) Revenue, Net Income and Gross profit
  • Figure 30. Myungmoon Pharm Co. (South Korea) Revenue: by Geography 2020
  • Figure 31. Baxter International (United States) Revenue, Net Income and Gross profit
  • Figure 32. Baxter International (United States) Revenue: by Geography 2020
  • Figure 33. Reliefband Technologies LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Reliefband Technologies LLC. (United States) Revenue: by Geography 2020
  • Figure 35. CVS Health (United States) Revenue, Net Income and Gross profit
  • Figure 36. CVS Health (United States) Revenue: by Geography 2020
  • Figure 37. Global Airsickness Treatment: by Type USD Million (2021-2026)
  • Figure 38. Global Airsickness Treatment: by Application USD Million (2021-2026)
  • Figure 39. Global Airsickness Treatment: by Type USD Million (2021-2026)
  • Figure 40. Global Airsickness Treatment: by Treatment USD Million (2021-2026)
  • Figure 41. Global Airsickness Treatment: by Route of Administration USD Million (2021-2026)
  • Figure 42. Global Airsickness Treatment: by Distribution Channel USD Million (2021-2026)
  • Figure 43. South America Airsickness Treatment Share (%), by Country
  • Figure 44. Asia Pacific Airsickness Treatment Share (%), by Country
  • Figure 45. Europe Airsickness Treatment Share (%), by Country
  • Figure 46. MEA Airsickness Treatment Share (%), by Country
  • Figure 47. North America Airsickness Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • GlaxoSmithKline plc (United Kingdom)
  • Perrigo Company plc (Ireland)
  • Prestige Brands (United States)
  • WellSpring Pharmaceutical Corporation (United States)
  • Caleb Pharmaceuticals (Taiwan)
  • Myungmoon Pharm Co. (South Korea)
  • Baxter International (United States)
  • Reliefband Technologies LLC. (United States)
  • CVS Health (United States)
Select User Access Type

Key Highlights of Report


Jun 2021 235 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Airsickness Treatment Market Quantitative research analysis
Global Airsickness Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.

Know More About Global Airsickness Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Dydrogesterone Drug Comprehensive Study by Type (Dydrogesterone, Dydrogesterone+Estradiol Compound), Application (Infertility, Gynecological Diseases, Threatened Abortion, Other), Distribution Channe...
$ 3800
Buckwheat Extract Comprehensive Study by Application (Food Supplements, Nutraceuticals Formulations, Dietary Supplements, Cosmeceuticals), Consumption (External, Internal), Form (Capsule, Tablet, Liq...
$ 3650
Biapenem Comprehensive Study by Type (150mg, 300mg, 600mg), Application (Sepsis, Pneumonia, Lung Abscess, Refractory Cystitis, Pyelonephritis, Peritonitis, Gynecologic Adnexitis), Sales Channel (Onli...
$ 3500
Soliris Comprehensive Study by Category (Plasma Exchange, Plasma Infusion), Indication (Atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH), Generalized Myasthenia Gr...
$ 3450
Antispasmodics Drugs Comprehensive Study by Type (Dicyclomine Hydrochloride, Loperamide Hydrochloride, Others), Route of Administration (Oral, Injectable, Sublingual, Others), Indication (Irritable B...
$ 3750
Hashimoto's Thyroiditis Drug Comprehensive Study by Type (Capsule, Powder, Tablet), Application (Hospitals, Clinics, Medical Laboratories, Others), Treatment (Levothyroxine, Triiodothyronine, Desicca...
$ 3750